Osaic Holdings
HELX icon

Osaic Holdings’s Franklin Genomic Advancements ETF HELX Stock Holding History

Osaic Holdings’s Portfolio HELX Stock Details HELX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Buy
3,142
+804
+34% +$27.9K ﹤0.01% 4774
2026
Q1 		$77.3K Sell
2,338
-794
-25% -$27.7K ﹤0.01% 4867
2025
Q4 		$114K Hold
3,132
– – ﹤0.01% 4603
2025
Q3 		$95.5K Hold
3,132
– – ﹤0.01% 4826
2025
Q2 		$86.8K Buy
3,132
+502
+19% +$13.3K ﹤0.01% 4625
2025
Q1 		$71K Buy
+2,630
New +$77.4K ﹤0.01% 4445
2024
Q4 		– Sell
-2
Closed -$66 – 7513
2024
Q3 		$66 Sell
2
-182
-99% -$5.95K ﹤0.01% 7277
2024
Q2 		$5.83K Sell
184
-113
-38% -$3.54K ﹤0.01% 6096
2024
Q1 		$9.73K Sell
297
-100
-25% -$3.13K ﹤0.01% 5754
2023
Q4 		$12.1K Sell
397
-82
-17% -$2.28K ﹤0.01% 5738
2023
Q3 		$13.6K Sell
479
-141
-23% -$4.25K ﹤0.01% 5761
2023
Q2 		$18.7K Buy
620
+505
+439% +$15.3K ﹤0.01% 5609
2023
Q1 		$3.5K Sell
115
-904
-89% -$27.8K ﹤0.01% 6495
2022
Q4 		$31K Hold
1,019
– – ﹤0.01% 5273
2022
Q3 		$30K Buy
1,019
+2
+0.2% +$66 ﹤0.01% 5295
2022
Q2 		$33K Hold
1,017
– – ﹤0.01% 5255
2022
Q1 		$38K Hold
1,017
– – ﹤0.01% 5283
2021
Q4 		$49K Sell
1,017
-88,027
-99% -$4.39M ﹤0.01% 5162
2021
Q3 		$4.66M Buy
89,044
+87,472
+5,564% +$4.73M 0.01% 1101
2021
Q2 		$81K Buy
1,572
+512
+48% +$22.9K ﹤0.01% 4659
2021
Q1 		$46K Buy
1,060
+505
+91% +$23.6K ﹤0.01% 4933
2020
Q4 		$25K Buy
+555
New +$22.1K ﹤0.01% 5015

Other funds holding HELX

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Osaic Holdings's HELX Position: Q2 2026 in Review

Osaic Holdings increased its Franklin Genomic Advancements ETF (HELX) stake by 34% in Q2 2026, buying an estimated $27.9K and bringing the position to 3,142 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #4774.

Osaic Holdings first reported a position in HELX in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.66M in Q3 2021. 6 funds tracked by Wall St. Rank hold HELX as of Q2 2026.

  • Osaic Holdings held 3,142 shares of Franklin Genomic Advancements ETF worth $126K as of Q2 2026.
  • Osaic Holdings bought 804 Franklin Genomic Advancements ETF shares in Q2 2026, an estimated $27.9K.
  • Franklin Genomic Advancements ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4774 holding.
  • Osaic Holdings first reported a position in Franklin Genomic Advancements ETF in Q4 2020 and has held it in 22 quarters since.
  • Osaic Holdings's Franklin Genomic Advancements ETF position peaked at $4.66M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Franklin Genomic Advancements ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.